CRA x future.bio: Road to Phase I
We’re so excited to be co-hosting our next event with Charles River Associates, one of the UK’s leading life sciences consultancies. CRA and future.bio are working to bring #founders and #pharma together around the table to discuss the “Road to Phase I” and the challenges that tech x bio companies face in approaching the clinic.
Many tech x bio companies now face the translation of their #platform approaches toward more #asset-driven models, and as Series A+ financing gets more competitive, the pressure to get that first pharma partnership or IND data package is more intense than ever.
Come and join us on the 5th of September to discuss and share learnings across stages, indications and modalities.
All tech x bio founders building asset-driven companies are welcome to join us, from pre-seed all the way to clinical stages.
Many thanks to CRA for hosting us in their London offices